THE EFFECT OF ONLINE TRAINING ON FOOT CARE

Sponsor
Maltepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05473494
Collaborator
(none)
90
1
2
8
11.3

Study Details

Study Description

Brief Summary

The aim of this study is to determine the effect of online trainings on diabetic foot care on foot care behavior and self-efficacy attitudes of individuals with type II diabetes.

Purpose in accordance with the patient's Diagnostic Information Form, diabetic foot care self-efficacy Scale(DABOO), foot care Behavior Scale(ABDO) and diabetic foot risk screening forms are available in the data collection tools; education and Research Hospital Internal Medicine outpatient clinic with Deeply Izmit Seka state hospital, inpatient or outpatient treatment for persons with Type II diabetes who agree to volunteer to participate in research 90 shall apply. After that, the groups will be divided into two groups by randomization, and one of the groups will be given training sessions consisting of min 20 max 40 minutes for diabetic foot care in 5 sessions for nine weeks. After the training, the scales will be applied to the groups again. The data obtained before and after the training will be compared statistically in a computer environment

Condition or Disease Intervention/Treatment Phase
  • Other: training group
  • Other: control group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Health Services Research
Official Title:
THE EFFECT OF ONLINE TRAININGS ON DIABETIC FOOT CARE ON FOOT CARE BEHAVIOR AND SELF-EFFECTIVENESS ATTITUDES OF INDIVIDUALS WITH TYPE II DIABETES
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Aug 25, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: training group

Other: training group
Trainings on diabetic foot care consisting of min 20 max 40 minutes will be given in 5 sessions for nine weeks. Training will be given face to face online.

Active Comparator: control group

Other: control group
Group not to be trained.

Outcome Measures

Primary Outcome Measures

  1. Diabetic Foot Care Self-Efficacy Scale [nine weeks]

    Self-efficacy is measured by scoring between 0 and 10. The 9 expressions that make up the scale are evaluated on the 11-digit visual scale, which is specified as -Not sure=0 and very sure=10. The lowest score of the scale is 0 and the highest score is 100. As the score obtained from the scale increases, the diabetic foot self-efficacy level increases in parallel.

Secondary Outcome Measures

  1. Foot Care Behavıor Scale [nine weeks]

    Consisting of 15 items in a 5-point Likert type, the scale is scored according to agree-disagree (1= Never, 2= Occasionally, 3= Sometimes, 4= Often, and 5= Always) and consists of 15 items. The lowest score that can be obtained from the scale, which evaluates foot care behavior as a single dimension, is 15 and the highest score is 75. An increase in the scale score indicates that the individual's foot self-care behaviors become positive.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients who were applied the Dietetic Foot Risk Screening form during the physician's examination and who were in the low and medium risk groups after the physician's examination.

  • To be able to read and write.

  • Being between the ages of 18-65.

  • Being on oral antidiabetic (OAD) and/or insulin therapy.

  • No restriction of access to the Internet.

  • To be able to use the Zoom program or WhatsApp video conversation with or without support.

  • Having computer and/or telephone skills.

  • Volunteering to participate in the study (Informed consent form will be signed by the participants during the application)

  • Not having sensory loss such as speech and hearing that prevents communication and no psychiatric problems.

Exclusion Criteria:

outside the inclusion criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ev Kocaeli Izmit Turkey 41500

Sponsors and Collaborators

  • Maltepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ayşegül Kandemir, Principal Investigator, Maltepe University
ClinicalTrials.gov Identifier:
NCT05473494
Other Study ID Numbers:
  • 2021/33-03
First Posted:
Jul 26, 2022
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayşegül Kandemir, Principal Investigator, Maltepe University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022